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In bacteria and fungi, nonribosomal peptide synthetase (NRPS) systems produce 
secondary metabolites that often possess anti-microbial, anti-fungal, anti-cancer, or other 
biological activities (1). Since microorganisms continue to develop resistance against known 
pharmaceutical treatments, the need for new drugs remains critical. Analyses of bacterial 
genomes reveal many more biosynthetic gene clusters than the number of known metabolites 
produced in a given species. Previous investigations of such cryptic clusters resulted in the 
discovery of novel secondary metabolites (2-5). This project evaluated two cryptic NRPS 
biosynthetic gene clusters encoded in the Streptomyces laurentii ATCC 31255 (S. laurentii) 
genome: nrps2 and nrps3. Bioinformatic analyses of the S. laurentii genomic data allowed for 
the identification of these two cryptic NRPS biosynthetic gene clusters and a proposal of the core 
structures for the associated products. Determination of the loci of the nrps2 and nrps3 clusters 
involved the polymerase chain reaction (PCR), cloning, sequencing, and bioinformatic analysis. 
The bioinformatic analyses predict that the NRPS3 system produces a novel nonribosomal 
peptide. On the other hand, NRPS2 is predicted to produce a blue pigment, indigoidine, a 
metabolite previously isolated from Streptomyces virginiae MAFF 6014, Streptomyces 
lavendulae ATCC 11924, and Erwinia chrysanthemi. Thus, S. laurentii is established as an 
alternate producer of that compound (6-8). For NRPS2, characterizing the protein and identifying 
the metabolite produced also required PCR and cloning in addition to metal-chelate affinity 
chromatography of the heterologously-expressed protein, fast protein liquid chromatography 
(FPLC), in vitro assays, and high performance liquid chromatography (HPLC). Inducing 
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production of the new compound in vivo was attempted, and future genetic disruption studies in 
conjunction with genetic and chemical complementation assays will confirm that the proteins 
encoded within the genetic cluster are responsible for blue pigment biosynthesis. Study of 
NRPS2 as an additional indigoidine-producing enzyme illuminates critical residues and motifs 
that are responsible for the unusual chemistry performed by these enzymes. Overall, the results 
from both projects aid in the continued battle against microbes, cancer, and other human disease 
states by adding either a new source for a known metabolite or a new peptide product, which 




CHAPTER 1: INTRODUCTION 
 
 
The constant and exponential increase in drug-resistant microorganisms and viruses 
perpetuates an urgent need for new pharmaceutical agents (9). The past few millennia 
demonstrate the importance of naturally-produced anti-infective agents in medicine: among 
others, the Egyptians, Chinese, Indians, Greeks, Romans, and Arabs documented the use of 
naturally-available substances for medicinal purposes (10). Between 1981 and 2002, products 
derived from natural sources comprised 60% of new anticancer pharmaceuticals and 75% of new 
drugs used to treat infectious diseases  (11). Bacteria naturally produce many of the 
pharmaceuticals used in the past and present including some of the β-lactam antibiotics, the 
nikkomycins, vancomycin, the tetracyclines, and bacitracin (12-16). More specifically, the 
actinomycetes, especially the genus Streptomyces, contribute a significant portion of the 
secondary metabolites useful in medicine. Although bacteria can produce these metabolites 
under specialized laboratory conditions, such as S. laurentii with thiostrepton, certain potentially-
useful compounds are generated only under nutritional or environmental stress as a coping 
strategy or defense mechanism or are produced in response to inducing molecules or other 
specific ingredients in the medium (17,18). Some biosynthetic clusters have no known associated 
product. These clusters are cryptic, and their products are orphan metabolites. Manipulating 
bacteria to successfully deliver the compounds encoded by cryptic clusters provides additional 
resources for drug discovery in the fight against cancer and infectious diseases. With the 
continuous and drastic increase in antimicrobial-agent-resistant strains of harmful viruses, fungi, 
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and bacteria, finding new natural product drug leads and ways to manipulate their biosyntheses 
to compensate for resistance or drug-delivery issues becomes paramount.  
This study predicts the backbone structure of peptides produced by two NRPS systems. 
For one system in this study, the enzyme has been purified, and in vitro assays have been 
conducted, but further study and protocol modification is required. Future work on these projects 
will result in at least one novel metabolite that may contribute to the fight against cancer or 
infectious diseases.  Additionally, improved understanding of the enzyme machinery of these 






Various biosynthetic systems afford the production of natural products including NRPS 
and polyketide synthase (PKS) systems. NRPS and PKS systems are found in many antibiotic-
producing families of bacteria, including the Streptomyces genus of actinomycetes, and these 
systems yield two large classes of secondary metabolites beneficial to the battle against disease 
(1,15). Secondary metabolites produced by NRPS and PKS systems arise from modular 
enzymatic assembly lines (15). Hybrid PKS-NRPS and NRPS-PKS systems also exist, such as 
those found in the indanomycin, myxothiazol, or melithiazol biosynthetic clusters in 
Streptomyces antibioticus NRRL 8167, Stigmatella aurantiaca DW4/3-1, Melittangium 
lichenicola Me l46 respectively (19,20). Polyketides are built from monomers of malonyl-
coenzymeA (malonyl-CoA) or one of its derivatives, but a different acyl-CoA thioester may 
serve as the starting substrate. On the other hand, proteinogenic and nonproteinogenic amino 
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acids serve as the substrates for NRPSs (15). Hybrid systems utilize both malonyl-CoA thioesters 
and amino acids according to the modules of the individual biosynthetic system. Polyketides and 
nonribosomal peptides may be modified following megasynthetase assembly or, in certain cases, 
their monomeric components may be modified pre-assembly (15). Typically, all genes encoding 
the necessary modifying enzymes are clustered next to each other on the bacterial chromosome 
(15). Research on these significant compounds requires understanding their composition and 
biosynthesis. 
 
Overview of nonribosomal peptide synthetase systems 
 
 
This study focuses on NRPS systems due to the large number of cryptic NRPS clusters 
found in the S. laurentii genome (21). Figure 1.1 displays the modular and domain organization 
of a typical NRPS, which includes an initiation, extension, and termination module. In a NRPS 
system, one module typically exists for each monomer to be incorporated into the metabolite. 
Three core domains present in almost all NRPS systems are the carrier protein or the thiolation 
(T) domain, the amino acid adenylation (A) domain, and the condensation (C) domain (15). The 
T domain is posttranslationally modified at a conserved serine residue by a phosphopantetheinyl 
transferase (PPTase) to bear a phosphopantetheinyl arm that covalently binds the amino acid 
substrate (15). The A domain determines the amino acid monomer to be incorporated and 
tethered to the T domain by a two-step process. It first catalyzes the formation of an aminoacyl-
adenylate intermediate using adenosine-5’-triphosphate (ATP) coordinated with magnesium (II) 
(Mg2+) and releasing inorganic pyrophosphate (PPi), and, in a second step, the A domain then 
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Some domains do not always appear in an NRPS module. These include epimerization 
(E), heterocyclization (Cy), oxidase (Ox), methyltransferase (MT), dual-function condensation-
epimerization (C/E), monooxygenase (MonoOx), and aminotransferase (AMT) domains (Figure 
1.1) (15,20). E domains convert L amino acids to their D forms, while C/E domains perform both 
condensation and epimerization functions (25,32). Cy domains catalyze amide bond formation 
using cysteine, serine, or threonine as the acyl acceptor followed by attack of the β-thiol or β-
hydroxyl side chain upon the resulting amide carbonyl during cyclodehydration to yield a 
thiazoline or oxazoline ring (26,28). Ox domains often appear in the same module as a Cy 
domain to catalyze the oxidation of the heterocycle to the fully aromatic species (29,30). After 
amide bond formation, MT domains transfer a methyl group from S-adenosylmethionine to the 
amide nitrogen of the aminoacyl-S-T intermediate, (27,28,33). In hybrid NRPS-PKS systems, 
AMT domains transfer the α-amino group from glutamine to a β-ketoacyl group tethered to a T 
domain resulting in a β-aminoacyl-S-T intermediate as observed in the mycosubtilin PKS-NRPS 
system (24). The rarely seen MonoOx domains introduce a hydroxyl group at the α-position of 
the nascent peptidyl-S-T intermediate; this action can result in an intermediate which 
spontaneously decomposes into a peptide containing a carboxy-terminal amide and glyoxylate or 
another α-keto acid remaining bound to the T domain (20,31). The latter ultimately requires 
release by the TE domain (20,31). These domains occur less frequently than the C, A, and T, and 






Analyzing sequences for conserved motifs and substrate specificity in NRPS systems 
 
 
Extensive analysis on the deduced amino acid sequences of the NRPSs is based on the 
work of Marahiel, Stachelhaus, Challis, Rausch, and Conti (34-38). Alignment of the amino acid 
sequences of multiple NRPS domains reveals conserved sequence motifs as reviewed by 
Marahiel (36). These motifs include residues necessary for protein function or structure and are 
displayed in Table 1.1 (36). Based on the crystal structure of the A domain of gramicidin S 
synthetase A (PheA), the A1 and A2 motifs are conserved for structural reasons but do not 
participate in the adenylation domain reactions (35). The residues of the A3 motif stabilize the 
pyrophosphate leaving group, while the aspartic acid residue of the A7 motif interacts via 
hydrogen bonding with the ribose moiety of ATP (39-41). The aspartate residue in the A4 motif 
is thought to stabilize the α-amino group of the amino acid substrate via two hydrogen bonds and 
proves critical for correctly positioning the substrate within the active site for ATP-dependent 
activation (41-44).  In the A5 motif, the side chain carbonyl of the asparagine residue most likely 
forms a hydrogen bond with the amino group in the adenine of ATP based on mutational studies 
conducted by Saito, et al (41-44). The lysine residue in A10 coordinates with the α-carboxy 
group of the amino acid substrate and the ribose oxygens on the 4’ and 5’ carbons and is also 
presumed to fix the position of the amino acid and the ATP substrates (45). Mutation studies 
showed that the A8 sequence is critical for adenylate formation, and another study suggested that 
this sequence might participate in Mg2+ coordination, but the full role remains unclear (36,46-
48). The roles of the A6 and A9 motifs also remain unclear despite that the motifs still present 




Table 1.1  Highly conserved motifs of the domains of nonribosomal peptide 
synthetases (36). 
Domain Motif Consensus Sequence 
Adenylation A1 L(TS)YxEL 
A2  LKAGxAYL(VL)P(LI)D 
A3  LAYxxYTSG(ST)TGxPKG 
A4 FDxS 
A5 NxYGPTE 
A6  GELxIxGxG(VL)ARGYL 
A7  Y(RK)TGDL 
A8  GRxDxQVKIRGxRIELGEIE 
A9 LPxYM(IV)P 
A10 NGK(VL)DR 
Thiolation T  DxFFxxLGG(HD)S(LI) 







Thioesterase TE G(HY)SxG 







N-Methylation M1 VL(DE)GxGxG 
M2 NELSxYRYxAV 
M3 VExSxARQxGxLD 
*residues within parentheses indicate that either one or the other may be 
present and "x" indicates that any residue may be present.  
 
The variations in the A domain sequence between the A4 and A5 motifs specify the 
amino-acid substrate. These variations were analyzed by Stachelhaus, et al. and Challis et al. 
who aligned the amino-acid sequences of the region between the A4 and A5 motifs from NRPS 
subunits with known substrate specificities, including PheA (34,38). Based on the PheA crystal 
structure and these alignments, Stachelhaus, et al. identified ten amino acid residues that line the 
PheA active site and contact the substrate (35,38).  These residues appear to impart substrate 
specificity, and Stachelhaus, et al. prepared a chart detailing the various sequences that 
correspond to each potential substrate (38).  Rausch, et al. expanded on the work of Stachelhaus 
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et al. and Challis, et al. to create an algorithm which extracts the same ten substrate-specifying 
residues within 8 Å of the active site in the A domain (34,35,37,38). This algorithm then 
compares these residues with NRPS A domains of known specificity and statistically proposes a 
substrate for that A domain (37,38).  Although Rausch’s web-based program is a fast method to 
predict a NRPS module’s substrate and includes a more recent database than the previous work 
of Stachelhaus et al., aligning the sequences and manually identifying the specificity-conferring 
residues still provides beneficial guidance to such studies. 
 
Genome mining and the genomisotopic approach 
 
 
The preceding information provides a basic overview of NRPS system components 
required for this study, while the following tells of how this study came into being. The Kelly lab 
partially sequenced the S. laurentii genome in order to locate the biosynthetic gene cluster for 
thiostrepton, a ribosomally-produced antibiotic possessing potent activity against Gram-positive 
bacteria (49). During the course of that work, bioinformatic analyses identified NRPS homologs 
not associated with any known products of S. laurentii.  
Analyzing genetic data requires prior knowledge of genetics, biochemistry, and 
streptomycetes. Although notable exceptions exist, DNA is transcribed into RNA and then 
translated into proteins. Evolution has conserved protein structure and function in related species, 
genera, or families – and sometimes more broadly as shown by the highly conserved sequences 
of histone H4 among eukaryotes or cytochrome c in bacteria and mammals (50,51). The wealth 
of genomic data accumulated in publicly accessible databases provides insight into the function 
of an uncharacterized protein when the sequence of that protein is compared to a database of 
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proteins with a known role, its homologs. In streptomycetes, an inherent instability in the end 
regions of linear bacterial chromosomes causes members of this genus to gain and lose DNA, 
and thus novel functions, through lateral gene transfer in those terminal gene regions (52). That 
gene transfer makes genomes of related species crucial to analyzing a streptomycete’s genome 
and deducing protein function since  other species may have been the source of certain genes 
(52). Additionally, knowing the conserved core region for primary metabolism for a genus 
assists in identifying the potential loci for secondary metabolism. Investigating cryptic clusters 
starts with bioinformatic analyses and comparing genomic data from the organism of interest to 
that of related entities, in addition to sequentially-related proteins from a variety of systems. 
Both the Challis and Gross research groups pioneered methods to evaluate cryptic 
biosynthetic clusters.  These two methods both use the same bioinformatic analyses in the early 
stages of evaluating a cryptic cluster (3,5). To start, Ishikawa’s web-based FramePlot analyzes 
DNA sequences for open reading frames (orfs) in streptomycetes, taking into account the overall 
base composition within an orf, the guanosine and cytosine content of the third codon position 
(which averages 92% in streptomycetes), and potential ribosomal binding sites (RBSs) (53,54). It 
then deduces the corresponding amino-acid sequence and provides a link to the National Center 
for Biotechnology Information’s Basic Local Alignment Search Tool (BLAST) to check for 
known similar protein sequences (53,55). All of these steps facilitate prediction of protein 
function.  
Investigating any NRPS system requires a thorough bioinformatic analysis such as that 
described above, and the methods developed by Challis et al. and Gross et al. do not differ from 
each other in this respect.  Following the in silico analysis, however, the two methods diverge. 
For Challis, genome mining of cryptic NRPS and PKS biosynthetic clusters involves analyzing 
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genomic data using the tools already described here for all genes encoding proteins within a 
given locus that might participate in biosynthesis, not just the NRPSs (3). Cloning, expression, 
and purification of key proteins involved in the system can lead to in vitro reconstitution of all or 
part of the system. In vivo expression of the cluster in the native bacterium may be achieved by 
varying culture conditions in different media with and without inclusion of any inducer 
molecules (3). Following in vivo or in vitro production, nuclear magnetic resonance (NMR) 
spectrometry, HPLC and other methods aid in purification and structure determination of the 
metabolite. This genome mining method relies heavily on genetic data and analyses of that data; 
however, those analyses give a solid foundation for subsequent techniques and assays necessary 
to produce and detect the orphan metabolite. The Challis group and others applied this method to 
produce new compounds that include terrequinone, methylenomycin, fuscachelin, and 
coelichelin (56-59). 
In another approach, Gross, et. al. takes the bioinformatic analyses involved in genome 
mining, but applies that information differently in the quest to isolate and determine the product 
of a biosynthetic cluster (5). The genomisotopic approach applies the NRPS substrate predictions 
to propose experimental culture conditions in which the organism of interest may produce the 
novel compound (5). Predicting the function of an NRPS homolog and its anticipated substrate 
specificity remains necessary in this methodology (5). After narrowing down possible growth 
conditions, an isotopically-labeled substrate predicted for the NRPS may be added to the growth 
medium (5). Following the fate of the labeled isotope via NMR or mass spectrometry (MS) 
facilitates a fractionation scheme for product purification (5). This scheme consists of assays 
specific to the metabolite, and experimental conditions cannot always be predetermined. Gross, 
et al., pioneered this method while identifying the biosynthetic machinery that produces 
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orfamide A in Pseudomonas fluorescens Pf-5 (5). The genomisotopic method builds on the 
foundation of the genome mining of the Challis group by following isotope-labeled substrates 
and basing all subsequent assays on the information obtained from those marked substrates (3,5). 
Recently, Robbel et al. adapted this approach to elucidate a new nonribosomally-synthesized 
siderophore erythrochelin from Saccharopolyspora erythraea by adapting this approach (60). 
This alternative method appears equal in value when compared to that of Challis. The 
genomisotopic approach does not attempt to reconstitute the NRPS system in vitro prior to 
establishing in vivo production, eliminating the difficulties of expressing and purifying large 
NRPS subunits. Researchers mainly use a combination of genome mining and the genomisotopic 
approach to analyze genomic data and to explore the secondary metabolites that a given 
bacterium produces. 
 
Genome mining in Streptomyces laurentii 
 
 
Using a combination of the methods and strategies employed by Challis, et al, and Gross, 
et al, this thesis investigates two S. laurentii genome fragments encoding NRPS homologs that 
were identified during the search for the thiostrepton biosynthetic gene cluster: genome 
fragments 764 and 3305 (3,5).  The loci surrounding the S. laurentii genome fragments 764 and 
3305 were annotated as NRPS2 (Figure 1.2) and NRPS3 (Figure 1.3) respectively. Tables 1.2 
and 1.3 detail the orf and BLAST analyses of genome fragments 764 and 3305, respectively 
(53,55). Genome fragment 764 contains one orf encoding an incomplete NRPS homolog and two 
orfs encoding hypothetical proteins (55). Genome fragment 3305 includes two partial orfs which 
encode NRPS homologs and one complete orf encoding a stand-alone MonoOx domain. The 
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MonoOx domain encoded by orf3305b is comparable to that of the domain observed in the 
subunits MelG (52% identity and 65% similarity) and MtaG (53% identity and 66% similarity) 
associated with the hybrid NRPS-PKS systems that produce melithiazol and myxathiazol 
respectively (20,55). 
A PCR screen was used to pinpoint the biosynthetic locus for each system from the S. 
laurentii genomic fosmid library with primers specific to the NRPS-encoding genes and/or gene 
fragments (49). Once sequencing results confirmed that the identified fosmids possessed the 
intended sequences, one fosmid from each set was chosen for shotgun cloning and sequencing. 
This process was repeated as necessary to ensure that the complete locus was determined for 
each NRPS system. Extensive bioinformatic analyses were performed to determine all of the orfs 
within the obtained DNA sequence and to predict function based on homology and sequence 
identity. Once the NRPS homologs were identified, the deduced amino acid sequences for these 
homologs were further analyzed to determine the module and domain organization in addition to 
predicting the substrates and a possible core structure for each system. Following the 
bioinformatic analyses for the NRPS2 system, nrps2 was cloned into a protein expression vector, 
and that vector was transformed into the necessary E. coli strains. Protein expression and 
purification followed in addition to in vitro assays. 
 From the results, this study predicts that NRPS3 produces a novel metabolite for which 
the backbone structure is proposed, but further work is required to determine that product, to 
activate its production in vivo, and to characterize its biosynthesis. Additionally, this study 
establishes that S. laurentii possesses a gene, nrps2, which encodes an enzyme that produces a 
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All chemicals and solvents were reagent grade, purchased from VWR, Fisher, or Sigma-
Aldrich, and used without further purification unless otherwise indicated. Other reagents and kits 
for molecular biology techniques were purchased from NEB, Bio-Rad, Novagen, Qiagen, or 
Invitrogen. The Vector NTI application suite was purchased from Invitrogen/Life Technologies. 
All FASTA files and protein sequence descriptions were obtained from National Center for 
Biotechnology Information (NCBI), and protein-sequence alignments were performed using 
ClustalW (61,62). Individual sequencing reactions were performed by Eurofins MWG Operon 
(Huntsville, AL), and sequencing of the shotgun fosmid libraries was performed at Functional 
Biosciences, Inc. (Madison, WI). Protein-coding regions of DNA sequences were predicted 
using FramePlot 4.0Beta (http://nocardia.nih.go.jp/fp4/) (53). Protein sequences were analyzed 
by BLAST (Basic Local Alignment Search Tool) (55).   
Polymerase chain reactions (PCRs) were performed using a Robocyler Gradient 96 
(Stratagene). Agarose gels were run in a Labnet Gel XL Ultra V-2. Gels were visualized using an 
Alpha Innotech Corporation Imager. Beckman-Coulter Microfuge 18, Allegra X-15R, or 
Microfuge 22R centrifuges were used. E. coli was cultivated in a Barnstead Lab-line L-C 
incubator for solid media or, for liquid media, in a New Brunswick Scientific Innova 4230 
refrigerated incubator shaker or in a New Brunswick Innova 44 incubator shaker series. Fast 
Protein Liquid Chromatography (FPLC) was performed using an Amersham Biosciences ÄKTA 
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FPLC system with a UV-900, P900, pH/C-900, Box 900, and Fraction 900. A GE Health 
Sciences Mono Q 5/50 GL column was used for anion exchange chromatography. For 
ultraviolet-visible (UV-Vis) spectroscopy, a Varian Cary 50 UV-Visible spectrophotometer was 
used. High-performance liquid chromatography (HPLC) was performed on a Beckman Coulter 
System Gold equipped with a diode-array detector. 
Fosmid and plasmid DNA was purified following the Qiagen’s Plasmid Spin Miniprep 
Kit protocol. When a high concentration fosmid solution was desired, twice the recommended 
volume of the DNA-containing supernatant was applied to each Qiagen spin-column. The 
concentrations and purity of the isolated plasmid or fosmid DNA was assessed by UV-visible 
spectroscopy (63). 
All DNA primers were purchased from Integrated DNA Technologies. Table 2.1 lists the 
primers used in this study with the exception of primers used for sequence assembly which are 
detailed in Table 2.2. 
 
Bacterial strains, plasmids, and media 
 
 
The strains and plasmids used in this work are provided in Table 2.3. S. laurentii was 
obtained from American Type Culture Collection (ATCC).  All Escherichia coli (E. coli) strains 
were grown in Luria-Bertani liquid medium or on solid medium supplemented with the 
appropriate antibiotic(s). Kanamycin (50 μg/mL) and chloramphenicol (12.5 μg/mL) were used 
for the selective growth of E. coli. Tryptic Soy Broth (TSB) and Y6.5 were prepared as described 
(8,64). Y7.2 was prepared as for Y6.5 but at pH 7.2 (8). ISP-2, ISP-4, oatmeal, potato glucose 
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peptone (PGP), and Sabourad dextrose agar media were prepared as previously described (65-
68). Y6.5 agar was prepared by adding 18 g/L of Bacto agar to Y6.5 medium, and used for the 
growth and sporulation of S. laurentii (8).  
 
Table 2.1 Primers used in this study 
Primer Name Primer Sequence Purpose 
NRPS2-1 5' - CCCCGCCTCCTCCAGGAG - 3' Primers for screening the genomic library of 
S. laurentii for the NRPS2 biosynthetic gene 
cluster 
NRPS2-2 5' - CGAGGAGATCCTGCCGCC - 3' 
NRPS2-3  5’- GGCATATGCCGGGCGCGCGTCGC -3’ 
Primers for amplification of nrps2 for 
heterologous protein expression. The NdeI 
and XhoI restriction sites are underlined. 
NRPS2-4 5’- CTCGAGCTACCTCCCCAGCCGGTAGTG-3’ 
NRPS2-5 5’- CTCGAGCCTCCCCAGCCGGTAGTGGAT-3’ 
NRPS2-V1 5' - CGATCAGGAACAGGTTCTCC - 3' 
Primers for the confirmation of nrps2 
NRPS2-V2 5' - CTCTCCAGAGGCTCCAACTC - 3' 
NRPS2-V3 5' - TGTAGCCGGAGGACATGAAC - 3' 
NRPS2-V4 5' - AAGGAGTCCAAGCTCCAGGT - 3' 
NRPS2-V5 5' - ACCTGGAGCTTGGACTCCTT - 3' 
NRPS2-V6 5' - TCGCCTACGTCATCTACACG - 3' 
NRPS2-V7 5' - CCGGACGTGTAGATGACGTA - 3' 
NRPS2-V8 5' - CTGTTCGTCGCTGATCCTG - 3' 
NRPS2-V9 5' - CGTCGTAGAAGCGGTAGGTC - 3' 
NRPS2-V10 5' - GGCGAGGATCTCCCACTG - 3' 
NRPS3-1 5' - AAAACGACAGAGGGATCACG - 3' Primers for screening the genomic library of 
S. laurentii for the NRPS3 biosynthetic gene 
cluster 
NRPS3-2 5' - GGGTCGACGACAACTTCTTC - 3' 
NRPS3-3 5' - ATGAGAGGGAAAGGCGATCT - 3' Primers for screening the genomic library of 
S. laurentii to extend the NRPS3 locus 
upstream of forward end sequence 
NRPS3-4 5' - GACGATGTCGAACTCCTCGT - 3' 
NRPS3-5 5' - GATTCTCGAACGCTTTCTGC - 3' Primers for screening the genomic library of 
S. laurentii to extend the NRPS3 locus 
downstream of reverse end sequence 







Table 2.2 Sequencing primers for sequence assembly of fosmids JA18C3, JA4B8, JA9D12, 
JA5F6, & JA15F8 
Fosmid Primer  Primer Sequence   Fosmid Primer  Primer Sequence 
JA18C3 18C3-1 5’- GGATCACTGGACCCTGTACG - 3’   JA5F6 5F6-9 5' - GACGGAGATCTGTACGAGCA - 3' 
JA18C3 18C3-2 5' - GCGTTCCAGTTCGTCGAG - 3'   JA5F6 5F6-10 5' - GTAGCGGGTTCCGGTCAC - 3' 
JA18C3 18C3-3 5' - CCGAAGAGTAAGTCCCACCA - 3'   JA15F8 15F8-1 5' - GTTCGCGTACACCACCTACC - 3' 
JA18C3 18C3-4 5' - GCCTGATGCGGTATTTTCTC - 3'   JA15F8 15F8-2 5' - CCAGGGCGAGTTCGTACC - 3' 
JA18C3 18C3-5 5' - CGTCTGGGACCACTGACC - 3'   JA15F8 15F8-3 5' - ACTACCGTGCACACATGCTC - 3' 
JA18C3 18C3-6 5' - TGATTTCATCGAGCATGAGG - 3'   JA15F8 15F8-4 5' - GGTGAGGCTGATCTGGAAGA - 3' 
JA18C3 18C3-7 5' - CTGGCGTAATAGCGAAGAGG - 3'   JA15F8 15F8-5 5' - CGAACTCGACCACCTGGA - 3' 
JA18C3 18C3-8 5' - CTCCTTGGGCTCCCACTC - 3'   JA15F8 15F8-6 5' - TGGGTGAAGAACTCCAGGAT - 3' 
JA18C3 18C3-9 5' - CCGAAGAGTAAGTCCCACCA - 3'   JA15F8 15F8-7 5' - GATCAAGGACCGAACGTGAC - 3' 
JA18C3 18C3-10 5' - GTGACGTCGTCGCACACC - 3'   JA15F8 15F8-8 5' - CCGAGGTGTACCTGGGACT - 3' 
JA18C3 18C3-11 5' - TGATTTCATCGAGCATGAGG - 3'   JA15F8 15F8-9 5' - CAGCCGGAGACAGTCCAC - 3' 
JA4B8 4B8-1 5' - GCTCCTCCAGGTTCTCCTTC - 3'   JA15F8 15F8-10 5' - ACCCAGAACTCCTGGATGG - 3' 
JA4B8 4B8-2 5' - ATGAAGACCGTCGGTGAACT - 3'   JA15F8 15F8-11 5' - AAGGCGGCTTACGAGGAC - 3' 
JA9D12 9D12-1 5' - CCCGTACACATTGGTGACCT - 3'   JA15F8 15F8-12 5' - GTGCACGACGGCTTCTTC - 3' 
JA9D12 9D12-2 5' - AGCTTCGACGCGTTCTTCT - 3'   JA15F8 15F8-13 5' - TTCCGTCCTTCATGTGAACC - 3' 
JA9D12 9D12-3 5' - CAGTTCGCCCGAAGTGTT  -3'   JA15F8 15F8-14 5' - AACAGGTCGGTGGCGTACT - 3' 
JA9D12 9D12-4 5' - GTACGACGCTGGAGACGTG - 3'   JA15F8 15F8-15 5' - TGAAGAACTCCAGGATGTGG - 3' 
JA9D12 9D12-5 5' - GAGGATCTCGGCGAACAG - 3'   JA15F8 15F8-16 5' - CTCCCCACATGGAATGTCTT - 3' 
JA9D12 9D12-6 5' - CCACCTGGAACTCCTCCTG - 3'   JA15F8 15F8-17 5' - CCGAACGGCAAGATCGAC - 3' 
JA9D12 9D12-7 5' - GATGGCCAGCAGGGAATG - 3'   JA15F8 15F8-18 5' - CAGTTCATCGGCGTTTCC - 3' 
JA9D12 9D12-8 5' - CACGTCAACATGCCCTTC - 3'   JA15F8 15F8-19 5' - CCCTTCTGGTGGAGATTGTC - 3' 
JA9D12 9D12-9 5' - GACTACATGGTTCCCGCTGT - 3'   JA15F8 15F8-20 5' - GGATTCCTGGTCGTCCTGT - 3' 
JA9D12 9D12-10 5' - CGAGCTCCGCGTAACTGAG - 3'   JA15F8 15F8-21 5' - CCCTTCCTGTTGGTACGAGA - 3' 
JA9D12 9D12-11 5' - GTACGACGCTGGAGACGTG - 3'   JA15F8 15F8-22 5' - CAGGAAGAGGACCGAGGAC - 3' 
JA9D12 9D12-12 5' - CATGTACCCGGGGAGGTA - 3'   JA15F8 15F8-23 5' - ATGCCTCGTTCATCAGTGC - 3' 
JA5F6 5F6-1 5' - ACATGGACGGCGCTGTAG - 3'   JA15F8 15F8-24 5' - ACGCTGACCGACAAGGAC - 3' 
JA5F6 5F6-2 5' - CAGTCGTGGATCTGGAGCTG - 3'   JA15F8 15F8-25 5' - GCGTTTTCGGAGGGTACTAA - 3' 
JA5F6 5F6-3 5' - TCGGTTCAGTGGTGTACGAG - 3'   JA15F8 15F8-26 5' - GACGAGACCGATGAAGAACG - 3' 
JA5F6 5F6-4 5' - GGTCACCGTCTTCCTCGTC - 3'   JA15F8 15F8-27 5' - ACCAGCCCTGTGAACGTC - 3' 
JA5F6 5F6-5 5' - CCCCTACAGGCCTACGAGTC - 3'   JA15F8 15F8-28 5' - CTCGGAGGGTTTGGGAAC - 3' 
JA5F6 5F6-6 5' - CGACACCGTGTTCGTGAC - 3'   JA15F8 15F8-29 5' - GTCCTCCTTGGCCTTGTTC - 3' 
JA5F6 5F6-7 5' - GAGCAGACACCCGTCGAG - 3'   JA15F8 15F8-30 5' - CTTCTGGGCCTGTTCGAC - 3' 





Table 2.3 Strains and plasmids used in this study 
Strain/Plasmid Description Reference or 
Source 
Streptomyces strain   
S. laurentii ATCC 31255 Wild-type, thiostrepton producer ATCC 
   
E. coli strains   
   MACH1 Host for DNA cloning and manipulation Invitrogen 
   BL21(DE3) Host for protein expression Novagen 
   
Plasmids   
   pSC-B/pSC-A Plasmid for cloning and sequencing Agilent (69,70) 
   pSC-B-nrps2-N4 Plasmid containing nrps2 with engineered restriction sites for 
N-terminal hexahistidine tag 
This Study 
   pSC-B-nrps2-C7 Plasmid containing nrps2 with engineered restriction sites for 
C-terminal hexahistidine tag 
This Study 
   JA4B8 Fosmid containing partial NRPS2 cluster (49) 
   JA5F6 Fosmid containing partial NRPS3 cluster (49) 
   JA9D12 Fosmid containing partial NRPS3 cluster (49) 
   JA15F8 Fosmid containing partial NRPS3 cluster (49) 
   JA18C3 Fosmid containing partial NRPS2 cluster (49) 
   pET28b(+) Protein expression vector for N-terminal hexahistidine fusion 
protein 
Novagen 
   pET29b(+) Protein expression vector for C-terminal hexahistidine fusion 
protein 
Novagen 
   pET28b(+)-nrps2 Protein expression vector for N-terminal hexahistidine fusion 
protein of NRPS2 
This study 
   pET29b(+)-nrps2 Protein expression vector for C-terminal hexahistidine fusion 




DNA sequence analysis 
 
 
The DNA sequences obtained from pyrosequencing and shotgun sub-cloning and 
sequencing were pasted into the FramePlot 4.0 query screen to identify potential open reading 
frames (53). The following parameters were used during analysis: a window size of forty codons, 
a step size of one codon, a minimum orf length of twenty codons, a resolution of one bp/pixel, 
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showing incomplete orfs, a RBS of GACGAACGCTGGCGG, and possible start codons ATG 
(methionine), GTG (valine), and TTG (leucine). An NCBI BLAST protein search identified 
homologs of the encoded protein (55).  Results were tabulated. Deduced protein sequences were 
aligned with homologs using ClustalW (61,62). Further bioinformatic analysis was conducted as 
described in Chapter 1. 
 
Primer design & testing 
 
 
Primer3 v4.0 was used to design the primers for the PCR screen of the S. laurentii fosmid 
library, NRPS2 and NRPS3 gene cluster sequencing, and the sequencing primers required for the 
fosmid sequence assembly (Tables 2.1 and 2.2) (49,71). For PCR, each primer was prepared at a 
5 μM working solution in 10 mM Tris-HCl (pH 8.5), and the annealing temperature for each set 
was optimized using genomic S. laurentii DNA as a positive control and pCC1FOS, the empty 
parent fosmid, as the negative control.  
Each 25 μL reaction contained 10 ng template DNA, 20 nmol deoxynucleoside 
triphosphates (dNTPs), 5 pmol each of a forward primer and a reverse primer, and 1.25 U Taq 
polymerase in 5% dimethylsulfoxide (DMSO) and 10 mM Tris-HCl, 50 mM KCl, 3 mM MgCl2, 
pH 8.3. These conditions were used for screening the fosmid library and any other PCR where 
the fidelity of the amplified sequence was less crucial. Elongation times and annealing 






Screening for selected sequences in the S. laurentii genomic DNA fosmid library 
 
The S. laurentii fosmid library was screened by PCR for the desired sequence. Four rows 
from each 96-well plate of the fosmid library (48 clones) were combined and the fosmid pool 
isolated. The four primer pairs to screen the library were NRPS2-1/NRPS2-2, NRPS3-1/NRPS3-
2, NRPS3-3/NRPS3-4, and NRPS3-5/NRPS3-6 (Table 2.1). Individual rows (containing a pool 
of 12 clones) from each plate and individual clones were identified by iterations of PCR. The 
PCR products were cloned into the pSC-A vector and confirmed by sequence analysis. 
For each identified fosmid, a plasmid sublibrary was prepared using Invitrogen’s TOPO® 
Shotgun Subcloning Kit, and the sublibrary was submitted to Functional Biosciences for 
sequence analysis. The Contig Express application (VectorNTI suite) was used to assess 
sequence quality from the chromatograms as described by Luckey, et al. and to assemble the 
sequence of the genome fragment cloned into each fosmid (72). When necessary, additional 
sequencing primers were designed to close any gaps in the assembled sequence and generate one 
continuous sequence. These primers were prepared at 10 μM concentrations and sent to Eurofins 
MWG Operon with highly-concentrated fosmid DNA preparations. 
 
Expression and purification of NRPS2 
 
 
The gene encoding NRPS2 was amplified by PCR using primer pairs NRPS2-3/NRPS2-4 
and NRPS2-3/NRPS2-5 (Table 2.1) for the N-terminal and C-terminal hexahistidine fusion 
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protein constructs respectively. The product was cloned into pSC-B, confirmed by sequence 
analysis, digested with NdeI and XhoI, and ligated into appropriately digested pET28b(+) or 
pET29b(+) to provide pET28b(+)-nrps2 and pET29b(+)-nrps2. The resulting expression vectors 
were confirmed by sequence analysis.  
Pilot scale expression study. To assess the optimal temperature and IPTG concentration 
for NRPS2 production, an expression study was conducted in the following manner (outlined in 
Table 2.4). From glycerol stocks of E. coli BL21(DE3) harboring an expression vector, overnight 
cultures of pET28b(+), pET29b(+), pET28b(+)-nrps2, and pET29b(+)-nrps2 were grown 
separately in 3 mL LB broth supplemented with 50 μg/mL kanamycin at 37 °C. From each 
culture, 100 μL was used to inoculate 13 x 10 mL aliquots of LB broth supplemented with 50 
μg/mL kanamycin. Cultures were grown until the optical density at 600 nm (OD600) was 
approximately 0.5 A.U. to 0.6 A.U. At this time, cultures were moved to the appropriate shaking 
incubator to equilibrate the temperature for 10 min before the appropriate amount of isopropyl-β-
D-thiogalactopyranoside (IPTG) was added to induce protein expression. After the suitable 
induction period, cells were pelleted at 1439xg for 10 min, the supernatant removed, and the 
harvested cells were stored at -86 °C until ready for use.  Harvested cells were resuspended in 1 
mL of lysis buffer [20 mM Tris (pH 8.0), 500 mM NaCl, 2 mM imidazole, 10% glycerol, 1 
mg/mL lysozyme, 10 μg/mL deoxyribonuclease I, 2 mM MgCl2] and incubated at 4 °C for 30 
min. The cells were disrupted by sonication (8x10-s pulses with a 2 min pause between each 
pulse). A 100 μL aliquot of the crude lysate was retained, mixed in a 1:1 ratio with 2X SDS-
PAGE loading buffer, and stored at -20 °C until needed for SDS-PAGE (63). The lysate was 
clarified via centrifugation at 4 °C; a 100 μL aliquot was retained for SDS-PAGE under the same 
conditions as the crude lysate. To the cell-free extract, 100 μL of Ni-NTA resin was added, and 
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the slurry was incubated at 4 °C for 30 min. The resin was pelleted at 640xg for 1 min, and the 
supernatant was discarded. A 500 μL wash with lysis buffer was added, and the resin was 
pelleted as above, and the supernatant was discarded again.  The resin was resuspended in 100 
μL of elution buffer [20 mM Tris (pH 8.0), 500 mM NaCl, 300 mM imidazole, 10% glycerol, 
2 mM MgCl2], pelleted as above, and the supernatant was retained for SDS-PAGE. Each sample 
was analyzed by SDS-PAGE. 
Table 2.4 Expression Study to determine optimum protein expression conditions 









Vector in E. coli 
BL21(DE3) 
1 (OD600 control) N/A N/A N/A pET29b(+) 
2 (OD600 control) N/A N/A N/A pET29b(+)-nrps2 
3 0 37 3 pET29b(+) 
4 0.4 37 3 pET29b(+) 
5 0.04 37 3 pET29b(+) 
6 0 37 3 pET29b(+)-nrps2 
7 0.4 37 3 pET29b(+)-nrps2 
8 0.04 37 3 pET29b(+)-nrps2 
9 0 28 6 pET29b(+) 
10 0.4 28 6 pET29b(+) 
11 0.04 28 6 pET29b(+) 
12 0 28 6 pET29b(+)-nrps2 
13 0.4 28 6 pET29b(+)-nrps2 
14 0.04 28 6 pET29b(+)-nrps2 
15 0 15 24 pET29b(+) 
16 0.4 15 24 pET29b(+) 
17 0.04 15 24 pET29b(+) 
18 0 15 24 pET29b(+)-nrps2 
19 0.4 15 24 pET29b(+)-nrps2 
20 0.04 15 24 pET29b(+)-nrps2 
21 0 15 48 pET29b(+) 
22 0.4 15 48 pET29b(+) 
23 0.04 15 48 pET29b(+) 
24 0 15 48 pET29b(+)-nrps2 
25 0.4 15 48 pET29b(+)-nrps2 




Table 2.4, continued 









Vector in E. coli 
BL21(DE3) 
1 (OD600 control) N/A N/A N/A pET28b(+) 
2 (OD600 control) N/A N/A N/A pET28b(+)-nrps2 
3 0 37 3 pET28b(+) 
4 0.4 37 3 pET28b(+) 
5 0.04 37 3 pET28b(+) 
6 0 37 3 pET28b(+)-nrps2 
7 0.4 37 3 pET28b(+)-nrps2 
8 0.04 37 3 pET28b(+)-nrps2 
9 0 28 6 pET28b(+) 
10 0.4 28 6 pET28b(+) 
11 0.04 28 6 pET28b(+) 
12 0 28 6 pET28b(+)-nrps2 
13 0.4 28 6 pET28b(+)-nrps2 
14 0.04 28 6 pET28b(+)-nrps2 
15 0 15 24 pET28b(+) 
16 0.4 15 24 pET28b(+) 
17 0.04 15 24 pET28b(+) 
18 0 15 24 pET28b(+)-nrps2 
19 0.4 15 24 pET28b(+)-nrps2 
20 0.04 15 24 pET28b(+)-nrps2 
21 0 15 48 pET28b(+) 
22 0.4 15 48 pET28b(+) 
23 0.04 15 48 pET28b(+) 
24 0 15 48 pET28b(+)-nrps2 
25 0.4 15 48 pET28b(+)-nrps2 
26 0.04 15 48 pET28b(+)-nrps2 
 
The N-terminal hexahistidine fusion protein construct was chosen for large-scale 
expression. E. coli BL21(DE3) containing pET28b(+)-nrps2 was incubated at 37 °C overnight in 
1 × 50 mL Luria-Bertani medium supplemented with 50 μg/mL kanamycin. The following 
morning, 4 × 10 mL and 1 × 5 mL of the overnight culture was used to inoculate 4 × 1 L and 
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1 x 500 mL of Luria-Bertani medium supplemented with 50 μg/mL kanamycin, and the resulting 
cultures were grown at 37 °C until OD600= 0.4. At this time, the temperature was reduced to 15 
°C and protein expression induced with the addition of 0.04 mM isopropyl-β-D-
thiogalactopyranoside (IPTG). Cultures were incubated for an additional 24 h. Harvested cells 
were resuspended in 30 mL of lysis buffer [20 mM Tris (pH 8.0), 500 mM NaCl, 2 mM 
imidazole, 10% glycerol, 1 mg/mL lysozyme, 10 μg/mL deoxyribonuclease I, 2 mM MgCl2]. 
The cells were disrupted by sonication (8x10-s pulses with a 2 min pause between pulses). The 
lysate was clarified by centrifugation (30000xg, 4 °C, 30 min).  The cell-free extract was 
incubated with 4 mL of Ni-NTA resin (Qiagen) for 1.5 h. The slurry was loaded onto a column, 
and the resin was washed with 20 mL lysis buffer and then with 25 mL wash buffer [20 mM Tris 
(pH 8.0), 500 mM NaCl, 20 mM imidazole, 10% glycerol, 2 mM MgCl2]. Protein was eluted 
with a step gradient of 6 mL of elution buffers 1 to 6 [wash buffer containing 40, 60, 80, 100, 
150, and 300 mM imidazole], collecting 6 mL fractions. Fractions containing the N-terminal 
hexahistidine tagged NRPS2 protein were pooled together and dialyzed against 2 × 1 L low salt 
buffer [50 mM Tris (pH 7.5), 50 mM NaCl, 10% glycerol, 2 mM MgCl2, and 2 mM DTT]. The 
protein was concentrated with a Millipore-100 kDa molecular weight cut off (MWCO) 
centrifugal filter, and loaded on to a GE Health Sciences Mono Q 5/50 GL column, equilibrating 
at low salt buffer conditions. The protein was eluted using a gradient of 50-500 mM NaCl over 
60 column volumes. Fractions containing NRPS2 were pooled together and dialyzed against 
2 × 1 L storage buffer [50 mM Tris (pH 8.0), 300 mM NaCl, 10% glycerol, 2 mM MgCl2, and 2 
mM DTT] and concentrated with a Millipore-100 KDa MWCO centrifugal filter. Protein 
concentration was determined by the method of Bradford, using bovine serum albumin as a 
standard (73). The protein was flash-frozen in liquid nitrogen and stored at -86 °C. Flavin 
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mononucleotide (FMN) concentration and fractional loading of NRPS2 by FMN were 
determined as previously described (74,75). 
 
 
Blue pigment production in S. laurentii 
 
 
 For liquid media, 10 μL of a S. laurentii spore suspension was used to inoculate 10 mL 
aliquots of three different media to which a proposed inducer, γ-nonalactone, was added: TSB, 
Y6.5, and Y7.2 (8,49,64). The inducer was diluted 10-fold with ethanol and to each culture, 3 μL 
was added for a final concentration of 30 μg/mL γ-nonalactone and 0.027% ethanol. Separate 
cultures were prepared to which γ-nonalactone  was added at 0, 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 20, 
24, 32, 40, 48, 56, 64, 72, 80, 88, and 96 h. Cultures were incubated at 220 rpm at 28 °C for 120 
h. The cells were pelleted at 1439xg for 10 min, and the supernatant was centrifuged with 
acetone in a 1:2 supernatant:acetone ratio to precipitate any blue pigment which might have been 
produced.  The pellets were resuspended in sterile deionized water and stored at -20 °C.  
 For solid media, 10 μL of a S. laurentii spore suspension was used to inoculate 10 mL of 
TSB which was grown for 48 h at 28 °C. For each media type, 3 plates were spread with 100 μL 
of the liquid culture, and a confluent plaque was allowed to develop.  Pictures were taken at 0 
and 18 h after which pictures were taken every 24 h.  The media used are as follows: ISP2, ISP4, 





NRPS2 in vitro blue pigment production 
 
 
 To assess the effect of temperature on the reaction catalyzed by NRPS2, reactions were 
performed at three temperatures: 15 °C, 25 °C, and 30 °C. To phosphopantetheinylate any apo-
NRPS2, 88.0 μL reactions containing 0.5 nmol NRPS2, 0.5 nmol Sfp, 200 nmol MgCl2, and 100 
nmol CoA in 50 mM sodium phosphate pH 7.8 were incubated for 30 min at 30 °C or 60 min at 
the other two temperatures. After this incubation period, 10 μL 30 mM ATP and 2 μL of 50 mM 
L-Gln were added. Final concentrations were 5 μM NRPS2, 5 μM Sfp, 2 mM MgCl2, 100 μM 
CoA, 3 mM ATP, and 1 mM L-Gln in 50 mM sodium phosphate (pH 7.8). The UV-Vis 
absorbance spectrum was monitored between 500 nm and 700 nm with an expected peak around 










































































































































 Fosmids JA18C3 and JA4B8 were subjected to shotgun sequencing. The resulting 
64.9 kb sequence was analyzed as shown in Table 3.1 and found to harbor a total of 66 open 
reading frames (orfs). From that analysis, an orf map was constructed. Figure 3.2 displays a 
current orf map for the NRPS2 locus spanning a 15 kb region and includes orf32 to orf43, since 
one enzyme, orf34, is expected to compose the complete NRPS system. A putative PPTase, 
orf42, lies downstream of nrps2 and is also shown since the apo-enzyme requires 
phosphopantetheinylation.  
 
Figure 3.2 Open reading frame map showing nrps2, orf34, in green and the putative PPTase-
encoding gene, orf42, in dark blue. Below the scale, the sequence span of each fosmid is shown. 
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Table 3.1 NRPS 2 Assembly (64920 bp)  - FramePlot and BLAST analysis 
Gene ID Strand Position aa Protein Homolog(s) (aa) Species 
%ID/ 
% Sim Proposed Function 










31/50 Unknown; possible similarity 
to a subunit of an α-keto acid 
dehydrogenase complex 
orf 3 + 1607-2545 312 Hypothetical protein Noca_1578 
(332 aa) 
Nocardioides sp. JS614 29/45 Unknown 
orf 4 + 2664-2915 83 DNA-binding protein (277 aa) Streptomyces sviceus 
ATCC 29083 
65/80 Unknown 





orf 6 - 3198-5075 625 Asparagine synthase, glutamine-
hydrolyzing (634 aa) 
Methanococcoides 
burtonii DSM 6242 
28/34 Amidotransferase 
orf 7 + 5163-5903 248 LmbE family protein (243 aa) Acidothermus 
cellulolyticus 11B 
55/69 Putative deacetylase 
orf 8 + 6170-7069 299 Hemerythrin HHE cation binding 
domain-containing protein (279 aa) 
Nocardioides sp.JS614 49/60 Unknown 
orf 9 + 7115-7621 168 Hypothetical protein 
TcurDRAFT_20260  (165 aa) 
Thermomonospora 
curvata DSM 43183 
60/76 Unknown 
orf 10 + 8136-8543 135 Endoribonuclease L-PSP 




“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 







Table 3.1, continued 
Gene ID  Strand Position aa Protein Homolog(s) (aa) Species 
%ID/% 
Sim Proposed Function 




62/76 Putative esterase 





62/72 Putative regulatory protein 




orf 14 + 11069-11944 291 DNA-binding protein (284 aa) Streptomyces 
pristinaespiralis ATCC 
25486 
61/73 Putative esterase 
orf 15 + 11901-12173 90 Conserved hypothetical protein (96 aa) Streptomyces 
pristinaespiralis ATCC 
25486 
66/77 Putative regulatory protein 





orf 17 + 13369-14922 517 Unknown (305 aa) Streptomyces fungicidus 28/40 Hypothetical nuclease 
    Endonuclease/exonuclease/phosphatas
e family protein (304 aa) 
Streptosporangium 
roseum DSM 43021 
35/49  
orf 18 - 15014-15928 304 β-Lactamase (304 aa) Streptomyces coelicolor 
A3 (2) 
74/85 Zinc-dependent hydrolase 




33/47 Unknown  




81/85 TetR family transcriptional 
regulator 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 






Table 3.1, continued 
Gene ID Strand Position aa Protein Homolog(s) (aa) Species 
%ID/ 
% Sim Proposed Function 





orf 22 + 18932-19330 132 Hypothetical protein FRAAL6818 
(265 aa) 
Frankia alni ACN14a 55/65 Unknown 
orf 23 - 19371-19664 97 Translation elongation factor Tu 
(405 aa) 
Coprothermobacter 
proteolyticus DSM 5265 
30/49 Unknown 




orf 25 + 20405-20905 166 Redoxin domain protein / thiol 




orf 26 - 21060-21857 265 DNA polymerase beta domain 




orf 27 - 22026-22652 208 Putative transmembrane protein 
(604 aa) 
Kordia algicida OT-1 32/51 Unknown 
orf 28 + 22817-24214 465 FAD linked oxidase domain protein 
(458 aa) 
Cyanothece sp. PCC 7425 54/69 FAD-linked oxidase 






orf 30 - 24646-25278 210 Hypothetical protein (200 aa) Streptomyces clavuligerus 81/90 Deaminase-reductase 
(NADH) 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 







Table 3.1, continued 
Gene ID  Strand Position aa Protein Homolog(s) (aa) Species 
%ID/% 
Sim Proposed Function 
orf 31 - 25481-26119 212 Hypothetical protein 













orf 34 - 26998-30915 1305 Putative indigoidine 
synthase IndC  (1283 aa) 
Streptomyces aureofaciens 58/71 NRPS subunit (A-Ox-T-
TE) 
orf 35 - 31158-31910 250 Conserved hypothetical 











orf 37 - 33325-34230 301 5,10-
methylenetetrahydrofolate 
reductase (286 aa) 
Streptomyces rochei 80/87 5,10-methylenetetrahydro
-folate reductase 





83/88 Methionine synthase 
orf 39 - 37733-38716 327 Putative adenosine kinase 
(327 aa) 
Streptomyces lavendulae 63/74 Kinase 
orf 40 - 38731-39939 402 SAM synthetase (402 aa) Streptomyces 
pristinaespiralis ATCC 
25486 
86/92 SAM synthetase 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 







Table 3.1, continued 
Gene ID  Strand Position aa Protein Homolog(s) (aa) Species 
%ID/% 
Sims Proposed Function 
orf 41 - 39936-40190 84 Hypothetical protein 
SGR_5184 (83 aa) 
Streptomyces griseus NBRC 
13350 
41/66 Unknown / putative 
carrier protein 
orf 42 - 40204-40650 148 Holo-acyl carrier protein 
synthase (125 aa) 
Halothermothrix orenii H 
168 
38/59 Phosphopantetheinyl 
transferase (ACPS family) 
orf 43 - 40652-41539 295 serS1 (350 aa) Streptomyces clavuligerus 
ATCC 27064 
45/58 Putative seryl-tRNA 
synthetase 
orf 44 - 41676-42569 297 Conserved hypothetical protein 
(291 aa) 
Streptomyces sviceus ATCC 
29083 
50/68 Unknown 





orf 46 - 43674-44516 280 Hypothetical protein 





orf 47 - 44774-45370 198 MaoC domain-containing 
protein (146 aa) 





orf 48 - 45505-46743 412 Methionine γ-lyase (396 aa) Saccharopolyspora 
erythraea NRRL 2338 
54/67 PLP-dependent protein, 
possible methionine 
γ-lyase or cystathionine 
β-lyase 
orf 49 - 46788-48242 484 Drug resistance transporter 






orf 50 + 48476-49189 237 Hypothetical protein 
SGR_3194 (253 aa) 
Streptomyces griseus NBRC 
13350 
68/77 Unknown 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 







Table 3.1, continued 
Gene 
ID Strand Position aa Protein Homolog(s) (aa) Species 
%ID/% 
Sim Proposed Function 









40/57 Unknown / putative regulatory 
protein 
orf 53 + 51057-51569 170 Putative acetyltransferase (175 aa) Streptomyces griseus 
NBRC 13350 
43/61 Acetyltransferase 
orf 54 - 51581-52477 298 Hypothetical protein SCO4676 (290 aa) Streptomyces coelicolor 
A3 (2) 
39/47 Unknown 
orf 55 - 52871-53488 205 Transcriptional regulator (207 aa) Streptomyces sp. Mg1 69/81 Transcriptional regulator 
orf 56 + 53560-53757 65 Hypothetical protein SSAG_03155  
(77 aa) 
Streptomyces sp. Mg1 50/75 Unknown 
orf 57 + 53754-53936 60 Hypothetical protein SSAG_03154 
(53 aa) 
Streptomyces sp. Mg1 45/69 Unknown 
orf 58 - 53933-54637 234 Cytidine/deoxycytidylate 
deaminase/NUDIX/methyltransferase 





orf 59 + 55057-56835 592 Hypothetical protein SSAG_03543 
(618 aa) 
Streptomyces sp. Mg1 27/38 Unknown 
orf 60 - 56984-58291 435 Metal-dependent hydrolase (430 aa) Flavobacterium sp. 
MED217  
29/46 Amidohydrolase / aminoacylase / 
carboxypeptidase 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 







Table 3.1, continued 
Gene ID Strand Position aa Protein Homolog(s) (aa) Species 
%ID/% 
Sim Proposed Function 
orf 61 + 58636-59928 430 Hypothetical protein SCO0012  / 
SCO7835 / SC8E7.32. (136 aa) 
Streptomyces 
coelicolor A3 (2) 
78/89 Unknowna 









80/87 Antibiotic resistance 





orf 64 - 62349-62723 124 Hypothetical protein SCO2859 
(125 aa) 
Streptomyces 
coelicolor A3 (2) 
91/93 Regulatory protein 









57/66 Regulatory protein 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 
same position as the homolog 
a Possible missing stop codon; good similarity for the first 117aa 




Nonribosomal peptide synthetase domain analysis and substrate specificity 
 
 
The sequence manipulation suite translated the deoxyribonucleic acid (DNA) sequence of 
nrps2 into a FASTA-format 1305 amino-acid sequence (76). ClustalW aligned the deduced 
amino acid sequence with provided amino acid sequences from known NRPSs, as detailed in 
Table 3.2  (61). These sequences were downloaded from NCBI and cut appropriately for their 
specific domains (62). The alignments of these NRPS homologs and NRPS2 were then analyzed 
for the modules, domains, and conserved motifs normally present within each NRPS domain. In 
addition, the A domain of NRPS2 was inspected for conserved amino acid residues that specify 
the amino acid monomer activated by the module (36-38,77,78). From this analysis, NRPS2 
lacks a C domain, but possesses A, Ox, T, and TE domains (Figure 3.3). Figures 3.4 and 3.5 
detail the motifs within the adenylation domain, while Figures 3.6, 3.7, and 3.8 display the 
conserved motifs within the Ox, T, and TE domains respectively. Table 3.3 gives the residues 
specifying the L-Gln substrate within the adenylation domain. The module and domain 
organization of NRPS2 mimics those of BpsA (57% identity, 69% similarity) and IndC (52% 
identity, 67% similarity), both of which produce indigoidine (6,7,55). It should be noted that a 







Figure 3.3 Module and domain organization of NRPS2, BpsA, and IndC. The source organism 





Table 3.2 Amino acid sequences used for alignments 
Abbreviated 
Name 
Name (aa) Species % ID/ % 
Sim 
BpsA Blue-pigment synthetase (1282 aa) S. lavendulae 58/71 
IndC Indigoidine synthetase (1488 aa) E. chrysanthemi 53/68 
LicA Lichenysin synthetase A (3582 aa) Bacillus licheniformis 36/51 
TycIII Tyrocidine synthetase 3 (6486 aa) Brevibacillus brevis 40/57 
BacA Bacitracin synthetase 1 (5255 aa) Bacillus licheniformis 35/54 
MycB Mycosubtilin synthetase B (5369 aa) Bacillus subtilis 37/53 
MtaC Myxothiazol synthetase C (1290 aa) Stigmatella aurantiaca DW4/3-1 33/50 
MtaD Myxothiazol synthetase D (3291 aa) Stigmatella aurantiaca DW4/3-1 32/47 
BlmIII Bleomycin synthetase III (935 aa) Streptomyces verticillus 26/41 
EpoB Epothilone synthetase B (1410 aa) Sorangium cellulosum 32/47 
EntF Enterobactin synthetase F (1293 aa) Escherichia coli Bl21(DE3) 36/53 
* % ID represents the percent of residues identical to NRPS2 while % Sim indicates the number of similar or 
identical residues to NRPS2. 
 
  
BpsA (1282 aa) 
Streptomyces lavendulae 
57% Identity, 69% Similarity 
IndC (1488 aa) 
Erwinia chrysanthemi 
52% Identity, 67% Similarity 
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Table 3.3 Substrate specificity alignments for the NRPS2 A domain 
GrsA position 235 236 239 278 299 301 322 330 331 517 
L-Gln per Stachelhaus, et al. (34,37,38) D A Q D L G V V D K 
BacA M4 (82) D A K D I G V V D K 
MycB M3 (79) D A Q D L G V V D K 
LicA M1  (81) D A Q D L G V V D K 
TycIII M2 (80) D A W Q F G L V V K 
IndC (6) D A W Q F G L I N K 
BpsA (7) D A W Q F G V I N K 
NRPS2 D A W Q Y G L I N K 
NRPS2 position 267 268 270 309 334 336 360 368 369 942 
Prediction L-Gln  
*M# (e.g. M1, M2, etc) refers to the order of the module within a subunit. All A domains used in this alignment with 
NRPS2 activate L-Gln. 
 
 
Expression and purification of NRPS2 
 
 
The pilot expression study of the N-terminal hexahistidine fusion construct of NRPS2 
revealed the production of a blue pigment when the host E. coli strain was cultivated at 15 °C for 
24 h. This pigment was not observed in the pET28b(+) cultures and was only observed to a lesser 
degree in the C-terminal hexahistidine fusion protein constructs of NRPS2 as shown in Figure 
3.8.  The expression study, in conjunction with the blue pigment production for the N-terminal 
hexahistidine NRPS2 construct, showed that a 24 h induction period with 0.04 mM IPTG at 15 
°C produced the most soluble fusion protein (Figure 3.8 and 3.9). The NRPS2 N-terminal 
hexahistidine fusion protein should be 144.4 kDa. Due to these observations, the cultures for the 
pilot expression study of the C-terminal NRPS2 hexahistidine construct were never evaluated for 
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In vitro blue pigment production 
 
To assess the capability of NRPS2 to produce a blue pigment in vitro, a reaction 
containing MgCl2, NRPS2, CoenzymeA, and Sfp, a promiscuous PPTase from Bacillus subtilis, 
in a buffered solution were incubated at one of three temperatures to phosphopantetheinylate 
NRPS2 (87). After an appropriate time, ATP and L-Gln were added to the solution, and the 
reaction was monitored by UV-Vis spectroscopy between 500 and 700 nm where the blue 
pigment was expected to produce a peak (7,8). The first set of results show an increase in 
absorbance peaking at 603 nm for the three temperatures used: 15 °C, 25 °C, and 30 °C. The 
greatest increase in absorbance was observed at 25 °C. For all three temperatures, the absorbance 
at 603 nm maximized at 5 min and decreased at later times.  
 
Figure 3.12 UV-Vis absorption spectrum from the in vitro blue pigment production assay at 
25 °C. Time points are denoted by the specified line color in the legend. Only the spectra for the 
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Figure 3.15 Partial open reading frame map for the NRPS3 locus. Orf30 to orf33 display nrps3a, 
nrps3b, nrps3c, and nrps3d, while orf42 and orf51 represent the genes encoding the putative 
PPTase and MbtH-like protein respectively.  The fosmids span the sequence as indicated by the 





30 35 40 45 50 55 60 65 70
Sequence Scale (kb) 
           nrps3a          nrps3b            nrps3c                            nrps3d                  orf42                 orf51 
51 
 
Table 3.4 NRPS3 Assembly (103052 bp) - FramePlot and BLAST analysis 




orf1 + 1-494 (i) 163 Peptide ABC transporter permease 
(907 aa) 
Streptococcus sanguinis SK36 26/45 Transporter 
orf2 + 491-3412 973 Sporulation protein K (931 aa) Streptomyces bingchenggensis 
BCW-1 
60/70 Sporulation protein 
orf3 - 3430-4485 351 Putative hydrolase (466 aa) Streptomyces scabiei 87.22 62/74 Hydrolase (glycosidic) 
    Ricin B lectin (496 aa) Actinosynnema mirum DSM 
43827 
67/77  
orf4 + 4561-4743 60 Conserved hypothetical protein 
(177  aa) 
Streptomyces sviceus ATCC 
29083 
32/58 Unknown 
orf5 + 5104-5526 140 Rare lipoprotein A (140  aa) Streptomyces violaceusniger 
Tu 4113 
75/86 Lipoprotein 
    Expansin family protein (143  aa) Streptomyces bingchenggensis 
BCW-1 
70/82  
orf6 + 5523-6239 238 Hypothetical protein 




    Superoxide dismutase (239  aa) Desulfovibrio desulfuricans 
subsp. desulfuricans str. G20 
34/50  
    Aminotransferase (504  aa) Salinibacter ruber DSM 
13855 
37/48  
orf7 + 6253-7131 292 Hypothetical protein 




orf8 - 7246-8772 508 Subtilisin-like protease (511  aa) Streptomyces avermitilis MA-
4680 
67/80 Protease 
orf9 + 9040-9507 155 Transcriptional regulator (154  aa) Streptomyces coelicolor A3(2) 86/92 Transcriptional regulator 
    MarR family transcriptional 




“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 






Table 3.4, continued 




orf10 + 9721-10929 402 Transmembrane efflux protein 
(397  aa) 
Streptomyces bingchenggensis 
BCW-1 
87/92 Membrane channel export 
protein 
orf11 + 10955-11323 122 Hypothetical protein 




orf12 + 11341-12180 279 Putative oxidoreductase 




orf13 + 12606-13691 361 Integral membrane protein 
(377  aa) 
Streptomyces pristinaespiralis 
ATCC 25486 
57/70 Putative serine/threonine 
phosphatase; membrane 
protein 
    Protein serine/threonine 
phosphatase (400  aa) 
Catenulispora acidiphila DSM 
44928 
45/63  
orf16 + 14007-15200 397 Conserved hypothetical protein 




orf17 - 15386-15865 159 Predicted protein (440  aa) Streptomyces sviceus ATCC 
29083 
51/62 Unknown 
orf18 + 16299-18329 676 Putative ABC transport protein 
(648  aa) 
Streptomyces sp. SPB78 81/89 ABC tranporter 
orf19 - 18525-19340 271 Aldo/keto reductase (345  aa) Saccharopolyspora erythraea 
NRRL 2338 
76/86 Oxidoreductase 
orf20 - 19782-21623 613 Asparagine synthase 
(glutamine hydrolyzing) 
(613  aa) 
Rhodococcus jostii RHA1 75/85 Asparagine synthase 
orf21 - 21999-22433 144 Putative IS630 family insertion 
sequence (363  aa) 
Streptomyces scabiei 87.22 89/91 Transposase sequence 
orf22 - 22511-23263 250 Hypothetical protein 
Noca_2884 (226  aa) 
Nocardioides sp. JS614 67/76 Reductase [2Fe-2S] 
    Ferredoxin (217  aa) Saccharomonospora viridis 
DSM 43017 
42/53  
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 





Table 3.4, continued 
Gene 
ID 




orf23 - 23260-24030 256 ABC-type cobalamin/Fe3+-
siderophore transport system, 
ATPase component  (251  aa) 
Saccharomonospora viridis DSM 
43017 
57/70 Iron uptake ABC 
transporter; ATPase 
component 
orf24 - 24072-25160 362 ABC-type Fe3+-siderophore transport 
system, permease component 
(354  aa) 
Saccharomonospora viridis DSM 
43017 
61/76 Iron uptake ABC 
transporter; permease 
component 
orf25 - 25157-26209 350 ABC-type Fe3+-hydroxamate 
transport system, periplasmic 
component (332  aa) 
Saccharomonospora viridis DSM 
43017 
56/70 Iron uptake ABC 
transporter; periplasmic 
component 
orf26 + 26629-27684 351 Major facilitator superfamily MFS_1 
(446  aa) 
Streptomyces sp. ACTE 81/84 Tranporter protein 
orf27 + 27681-28118 145 Pyridoxal-dependent decarboxylase 
(493  aa) 




orf28 + 28422-29666 414 Major facilitator superfamily MFS_1 
(418  aa) 
Bacillus cereus 172560W 34/57 Transmembrane 
transporter protein 




orf30 + 31749-35630 1293 Thaxtomin synthetase B (1505  aa) Streptomyces turgidiscabies Car8 48/59 NRPS (A-MT-T) 
orf31 + 35694-36740 349 Luciferase-like, subgroup (357  aa) Streptomyces violaceusniger Tu 
4113 
57/69 MonoOx domain  
    Nonribosomal peptide synthetase 
(3445  aa) 
Sorangium cellulosum 'So ce 56' 56/67  
orf32 + 36773-44635 2620 Amino acid adenylation  (4836  aa) Streptomyces violaceusniger Tu 
4113 
46/58 NRPS (C-A-T-C-A-T-E) 
orf33 + 44632-48546 1304 Putative NRPS (1323  aa) Streptomyces ghanaensis ATCC 
14672 
44/56 NRPS (C-A-T-TE) 
orf34 - 48720-49499 259 Hypothetical protein Caci_4314 
(494  aa) 
Catenulispora acidiphila DSM 
44928 
55/66 Transport protein 
    Cation diffusion facilitator family 
transporter (305  aa) 
Pyrobaculum arsenaticum DSM 
13514 
28/47  
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 




Table 3.4, continued 
Gene ID Strand Position aa Homolog(s) (aa) Species %ID/% Sim Proposed Protein 
Function 
orf35 + 49527-49772 82 Putative IS1647-like 
transposase (298  aa) 
Streptomyces griseus 
subsp. griseus NBRC 
13350 
62/81 Transposase (partial) 
orf36 - 49805-50443 212 Putative LysE family protein  
(209  aa) 
Kitasatospora setae 
KM-6054 
60/69 Amino acid 
transporter 
orf37 - 50555-50824 89 Homoserine/threonine efflux 




84/89 Amino acid exporter 
protein 
orf38 - 50916-52250 444 Sulfate adenylyltransferase 
subunit 1 (444  aa) 
Streptomyces scabiei 
87.22 
85/91 Sulfate adenylyl 
transferase  subunit 1 
orf39 - 52253-53188 311 Sulfate adenylyltransferase 
subunit 2 (311  aa) 
Streptomyces 
avermitilis MA-4680 
89/93 Sulfate adenylyl 
transferase  subunit 2 
orf40 - 53185-53793 202 Phosphoadenylyl-sulfate 
reductase (198  aa) 
Streptomyces sp. SPB74 74/82 Phosphoadenylyl-
sulfatereductase 
orf41 - 53793-55904 703 NikT protein (421  aa) Micromonospora sp. 
ATCC 39149 
64/71 Aminotransferase 





orf41.5 - 54749-54892 47 NikT protein (421  aa) Micromonospora sp. 
ATCC 39149 
69/78  
orf42 - 55973-56230 85 Phosphopantetheine-binding 
(85  aa) 
Frankia sp. EAN1pec 45/68 Acyl carrier protein 
orf43 - 56261-57298 345 4-Hydroxy-2-oxovalerate 
(354  aa) 
Micromonospora sp. 
ATCC 39149 
77/88 Carboxyl transferase 




    Acetaldehyde dehydrogenase 




“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 





Table 3.4, continued 




orf45 - 58238-59068 276 2-Hydroxypenta-2,4-dienoate 
hydratase (301  aa) 
Micromonospora sp. ATCC 
39149 
67/74 Hydrolase 
orf46 - 59664-60746 360 Streptomycin biosynthesis 
operon regulator (350  aa) 
Streptomyces griseus subsp. 
griseus NBRC 13350 
46/56 Transcriptional regulator 
protein 
orf47 - 60886-61248 120 Transthyretin family protein  
(108  aa) 
Mycobacterium abscessus 
ATCC 19977 
49/63 Hydrolase monomer 
orf48 - 61998-62327 109 Transthyretin (136  aa) Pseudomonas fluorescens 
Pf0-1 
30/50 Hydrolase monomer 
orf49 - 62478-65546 1022 Transcriptional regulator, SARP 
family (1022  aa) 
Streptosporangium roseum 
DSM 43021 
46/62 Transcriptional regulator 
orf50 - 65734-68499 921 ATPase-like protein (925  aa) Streptosporangium roseum 
DSM 43021 
51/65 Transcriptional regulator 
    Regulatory protein, LuxR 
(943  aa) 
Salinispora tropica CNB-440 39/53  
orf51 - 68897-69124 75 Putative MbtH-like protein 
(75  aa) 
Streptomyces ambofaciens 71/81 MbtH-like protein  
orf52 - 69264-70556 430 L-Lysine-ε aminotransferase Lat 
(446  aa) 
Mycobacterium marinum M 57/70 L-Lysine 
aminotransferase (ε 
amino group) 
orf53 - 70558-71202 214 HAD-superfamily hydrolase, 
subfamily IA, variant  (218  aa) 
Meiothermus silvanus DSM 
9946 
42/54 Hydrolase  
orf54 - 71202-72092 296 Spore coat polysaccharide 






    DTDP-4-dehydrorhamnose 
reductase (282  aa) 
Bacillus thuringiensis 
serovar monterrey BGSC 
4AJ1 
35/53  
orf55 - 72092-72766 224 Dimethylmenaquinone 
methyltransferase (228  aa) 
Vibrio shilonii AK1 42/62 Methyltransferase 
orf56 - 72842-74776 644 Transketolase central region 
(636  aa) 
Rhizobium leguminosarum 
bv. trifolii  
WSM1325 
50/64 Transketolase 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 




Table 3.4, continued 




orf57 - 74803-75564 253 Oxidoreductase, short chain 




orf58 - 75596-76663 355 N-acetylneuraminic acid 
synthase (365  aa) 
Rhodospirillum centenum 
SW 
55/69 Neuramic acid synthase 
orf59 - 76669-77997 442 Putative transcriptional 
regulator, GntR family (427  aa) 
Kribbella flavida DSM 
17836 
63/74 Transcriptional regulator 
or aminotransferase 
    Aminotransferase class I and II 
(441  aa) 
Micromonospora sp. ATCC 
39149 
63/74  
orf60 - 77994-79103 369 FMN-dependent alpha-hydroxy 
acid dehydrogenase (376  aa) 




orf61 - 79100-80137 345 4-hydroxyphenylpyruvate 





orf62 + 80356-81858 500 AMP-dependent synthetase and 
ligase (519  aa) 
Catenulispora acidiphila 
DSM 44928 
45/57 NRPS type II A domain 
orf63 + 81855-82979 374 O-methyltransferase (340  aa) Streptomyces tubercidicus 37/53 O-methyltransferase 
orf64 + 82986-84251 421 Cytochrome P450 
monooxygenase (405  aa) 
Saccharopolyspora 
erythraea NRRL 2338 
45/60 Cytochrome P450 
    NikQ protein (396  aa) Streptomyces tendae 36/53  
orf65 + 84275-84511 78 Nonribosomal peptide 
synthetase modules and related 
protein-like  
protein (2720  aa) 
Streptosporangium roseum 
DSM 43021 
64/69 NRPS type II T domain 
orf66 - 85070-85570 166 Secreted protein (169  aa) Streptomyces lividans TK24 39/53 Secreted protein 
orf67 + 85881-89828 1315 WD-40 repeat-containing 
protein (1303  aa) 
Streptomyces roseosporus 
NRRL 11379 
49/60 Transcriptional regulator 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 





Table 3.4, continued 




orf68 - 90004-91317 437 ATP/GTP-binding protein  
(444  aa) 
Streptomyces clavuligerus 
ATCC 27064 
40/55 Membrane protein / 
peptidase 
orf69 - 91489-91740 83 Conserved hypothetical 
protein (80  aa) 
Streptomyces sp. SPB74 45/56 Unknown 
orf70 - 91834-93063 409 PE-PGRS family protein 
(410  aa) 
Streptomyces sp. e14 70/80 Transcriptional regulator 
    Transcriptional regulator 




orf71 - 93130-94932 600 Amino acid adenylation 
(1345  aa) 
Anabaena variabilis ATCC 
29413 
42/59 NRPS subunit 
orf72 - 93068-95395 775 Hypothetical protein 
bcere0007_52480 (2787  aa) 
Bacillus cereus AH621 60/75 Seems to be frameshift 
linking orf71 and orf73 
orf73 - 93068-100411 1801 Amino acid adenylation 
domain protein (4836  aa) 
Streptomyces 
violaceusniger Tu 4113 
47/60 NRPS subunit 
orf74 + 100435-103052 (i) 871 Peptide synthetase (4898  aa) Streptomyces lavendulae 49/60 NRPS subunit 
“i” indicates an incomplete orf,  “aa” refers to the length of the polypeptide in amino acids; for strand, “+” indicates the direct strand, while “-“ indicates the 
complementary strand. % ID represents the percent of residues identical to the homolog while % Sim indicates the number of similar or identical residues in the 








Nonribosomal peptide synthetase domain analysis and substrate specificity 
 
Module and domain analysis was performed identically to that of NRPS2. This analysis 
indicates that NRPS3 is composed of four subunits. NRPS3A is predicted to have A-MT-T 
domains and activate L-phenylalanine whose α-amino group would be methylated by this 
subunit. NRPS3B shows significant similarity to MonoOx domains, but it is a discrete subunit. A 
MonoOx domain could hydroxylate a saturated carbon as it does in the myxathiazol and 
melithiazol systems (20,31). If the MonoOx domain acts on the glycine residue, it would 
facilitate a glyoxal leaving group as it does in the aforementioned systems, but it could also 
hydroxylate an aliphatic carbon on valine. NRPS3C is a dimodular subunit of C-A-T-C-A-T-E 
domain organization and is predicted to activate L-Val and Gly. The third module which 
activates Gly has an E domain; it is unclear which substrate the E domain epimerizes since Gly is 
achiral. NRPS3D is a single module subunit which is predicted to activate D-lysergic acid of 
domain organization C-A-T-TE.  Table 3.5 shows the proteins used for sequence alignments. 
Figure 3.16 shows the predicted partial peptide backbone for the NRPS3 system. Figures 3.17 
through 3.25 show the various alignments for the subunits. Table 3.6 gives the alignment of 































Table 3.5 Proteins used for sequence alignments with NRPS3 (62) 
Abbreviated Name Name Species 
ACMS III Actinomycin synthetase III Streptomyces anulatus 
BacA Bacitracin synthetase 1 Bacillus licheniformis 
CDAI  Calcium-dependent antibiotic peptide synthetase I Streptomyces coelicolor A3(2) 
CDAII Calcium-dependent antibiotic peptide synthetase II Streptomyces coelicolor A3(2) 
CDAIII Calcium-dependent antibiotic peptide synthetase III Streptomyces coelicolor A3(2) 
CtaG Cystothiazole A synthetase G Cystobacter fuscus 
EntF Enterobactin synthetase F Escherichia coli BL21(DE3) 
GrsA Gramicidin S synthetase 1 Aneurinibacillus migulanus 
GrsB Gramicidin S synthetase 2 Aneurinibacillus migulanus 
LPS2 Ergopeptine synthetase 2 Claviceps purpurea 
LtxA Lyngbyatoxin synthetase A Lyngbya majuscula 
MelG Melithiazol synthetase G Melittangium lichenicola 
MtaG Myxothiazole synthetase G Stigmatella aurantiaca DW4/3-1 
MycB Mycosubtilin synthetase B Bacillus subtilis 
PrisI-3,4 Pristinamycin synthetase 3,4 Streptomyces pristinaespiralis 
PseurotinA Pseurotin A synthetase Aspergillus fumigatus 
PstC Friulimicin synthetase C Actinoplanes friuliensis 
TxtA Thaxtomin A synthetase A Streptomyces acidiscabies 
TxtB Thaxtomin A synthetase B Streptomyces acidiscabies 
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CtaG            ISFDISVLEILYSLTRGFQVVLRGEQTTHPPVRAGASKPLEFSLFYFASDER-ERPGDKY 778 
MelG            MSFDISVLEIFYSLTRGFQVVLREERTTQQPVRAGASKPLEFSLFYFASDER-ERSGDKY 779 
MtaG            MSFDISILEILFSLTRGFQVVIRGEQGAGLPVSAGHRKAPQFSLFYFASDER-ESTHGKY 771 
NRPS3B          ---------------------------------------MDFSLFYFADDSTPDGDAGRY 21 
                                                        :*******.*.  :   .:* 
 
CtaG            RLLLEGARFADEHGFTAVWTPERHFHSFGGVYPNPSVISAAIAATTRNLRIRAGSVVLPL 838 
MelG            RLLMEGARFADEHGFTAVWTPERHFHSFGGIYPNPSVVSAAIAATTRNLRIRAGSVVLPL 839 
MtaG            QLLLEGARFADQHGFTAVWTPERHFHPFGGIFPNPSVVSAALAATTRNIRIRAGSVVLPL 831 
NRPS3B          ELLLEGARFADRHGFRAVWTPERHFHPFGGLYPNPSVVGAALAMVTNTVAIRAGSVVAPL 81 
                .**:*******.*** **********.***::*****:.**:* .*..: ******* ** 
 
CtaG            HSPIRVAEEWSVVDNLSGGRVDLSIASGWHPNDFVLAPERYADARSQLFSQLDSVRKLWR 898 
MelG            HSPIRVAEEWSIVDNLSGGRVDLSFASGWHPNDFVLAPERYAGARGQLMSQIEAFQKLWR 899 
MtaG            HSPIRVAEEWSIVDNLSNGRVDLSFASGWHPNDFVLAPERFADARSGLAGQIQTFKKLWR 891 
NRPS3B          HHPLRIAEEWSVVDNLSGGRAGVSLASGWHPVDFALGRVPYEDRKRALADGIEQLRGLWR 141 
                * *:*:*****:*****.**..:*:****** **.*.   : . :  * . :: .: *** 
 
CtaG            GEAVVFPNGLGQDVEVRTLPRPIQPDVAIWLTAAGNPETFRAAGERGLNVLTHLLGQNPA 958 
MelG            GEAVVFPNGLGQDVEVRTLPRPIQPDVAIWLTAAGNPETFRAAGERGLNVLTHLLGQNLA 959 
MtaG            GEKVNFRNGVGTDVAVQALPRPIQPDVAVWLTAAGNPETFRLAGELGTNILTHLLGQNLT 951 
NRPS3B          GDGHEVVDGNGVPATVRIFPPPVQRELPLWVTSAGDAGTFRTAAATRAGVLTHLLHQDVD 201 
                *:   . :* *  . *: :* *:* ::.:*:*:**:. *** *.    .:***** *:   
 
CtaG            ELAKKIQIYRDAWKAAGHGPGEGHVTLMLHTFLGEDPEAVRQKVQGPLRQYLKNSVGLLR 1018 
MelG            ELAKKIQIYRDAWKAAGHGPGAGHVTLMLHTFLGEDRGAVRQKIQGPLREYLKSSVGLLR 1019 
MtaG            ELEKKIQIYRDAWKAAGHGPGEGHVTLMLHTFVGDDAAEVRQKVQGPLRQYLKSSVGLLK 1011 
NRPS3B          ELAAKIAAYRRTARETHDG-WEGHVVLMLHTFLGTDRDEVRATVDGPLRAYLRSSVHLLA 260 
                **  **  ** : : : .*   ***.******:* *   ** .::**** **:.** **  
 
CtaG            SVIGPLQEGTEFESLGEADIELLLSRAIERYLDQMGLFGTVESCLPRVHQLRELGVDEIA 1078 
MelG            SVIGPLPHGAEFESLSEADIDVLLSKAIERYFEQMGLFGTVESCLPMVHQLRELGVDEIA 1079 
MtaG            TVIGPLAHGAEFESLSEADIDVLLSRAIERYQDQMGLFGTPESCLPMVAKLRDLGVDEIA 1071 
NRPS3B          RSFGALDPDFDIDALEDEDLDFLVDQSFDTYFGQRGLFGTVEDAAPVVERLRGAGVDEIA 320 
                  :*.*  . ::::* : *::.*:.:::: *  * ***** *.. * * :**  ****** 
 
CtaG            SLIDFGVDLESTLEGLRHLNALRERATSREEQEDLPTLVARHGVTHFQCTPSMLRMLLLE 1138 
MelG            SLIDFGVDMESTLAGLQHLNALRERATSREEKEEIPELVARHGVTHFQCTPSMLRMLLME 1139 
MtaG            CLIDFGVDRESTLAGLHHLNELRERSTQHGEPEDIPALVARHGVTHFQCTPSMLRMLLLE 1131 
NRPS3B          CLIDFGIGTKTVLDGLHHLNTLREASAAH------------------------------- 349 
                .*****:. ::.* **:*** *** :: :                                
 
Figure 3.24 ClustalW alignment for the MonoOx  domain of NRPS3B (61). No defined motifs 
for a MonoOx domain have yet been identified, but conserved residues appear throughout the 
domain sequence. CtaG is a subunit from the cystothiazole A synthetase of Cystobacter fuscus 
(99). MelG is a subunit from the melithiazol synthetase of Melittangium lichenicola (20). MtaG 
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Table 3.6 Substrate specificity alignments for NRPS3 subunits A, C, and D 
NRPS3A                     
GrsA position 235 236 239 278 299 301 322 330 331 517 
GrsA (L-Phe) (92,93) D A W T I A A I C K 
TycA (L-Phe) (80) D A W T I A A I C K 
TycB M2 (L-Phe) (80) D A W T I A G V C K 
NRPS3A  D A W T V A A V C K 
NRPS3A position 481 482 485 524 545 547 568 576 577 1161 
Prediction L-Phe 
NRPS3C module 1 
GrsA position 235 236 239 278 299 301 322 330 331 517 
GrsB - M2 (L-Val) (92,93) D A F L G A G T F K 
TycC - M4 (L-Val) (80) D A F L G A G T F K 
LicB - M1 (L-Val) (81) D A F L G A G T F K 
NRPS3C- M1 D A Y L G Q V T F K 
NRPS3C-M1 position 668 669 672 711 737 739 760 768 769 961 
Prediction L-Val 
NRPS3C module 2                     
GrsA position 235 236 239 278 299 301 322 330 331 517 
CDAII - M2 (Gly) (89) D I L Q V G L I W K 
DhbF - M1 (Gly) (101) D I L Q V G L I W K 
MelG (Gly) (20) D I L Q V G M I W K 
NosC - M2 (Gly) (102) D I L Q C G L I W K 
NRPS3C-M2 D I L Q V G V I W K 
NRPS3C-M2 position 1737 1738 1741 1780 1804 1806 1827 1835 1836 2032 
Prediction Gly 
NRPS3D                     
GrsA position 235 236 239 278 299 301 322 330 331 517 
CpaA (L-Trp) (90) D M A L C G S A C K 
pseurotin A (L-Trp) (91) D A Y T M A A I C K 
LPS2  (D-lysergic acid) (103) D V F S V G L V M K 
NRPS3D  D V F L V L I T Y K 
NRPS3D position  680 681 684 715 740 742 762 774 775 965 
LPS2 position 454 455 458 495 516 518 539 546 547 768 
Prediction D-lysergic acid 
 
The amino acid in parentheses indicates which amino acid is activated by the specific A domain. 









 The study of the NRPS2 system required identifying the genetic locus, extensive 
bioinformatic analysis, gene cloning, protein expression, protein purification, and in vitro assays. 
The NRPS2 system consists of a single NRPS subunit of one module consisting of A, Ox, T, and 
TE domains (Figure 4.1). It produces an unidentified blue pigment, as evidenced by the protein 
expression cultures in Escherichia coli. The blue pigment is most likely indigoidine, but attempts 
to purify it have not yet met with success. Confirmation of the blue pigment’s identity therefore 




Figure 4.1 Module and domain organization of NRPS2, BpsA, and IndC. The source organism 
and percent identity and similarity of NRPS2 to each protein are shown below each schematic 
(6,7,55). 
 
 A polymerase chain reaction (PCR)-based screen of the genomic fosmid library led to the 
identification of ten fosmids possessing S. laurentii genomic DNA fragment 764. From these 
fosmids, JA18C3 and JA4B8 were sequenced, analyzed and assembled to a 64920 bp fragment 
of the S. laurentii chromosome. Analysis of the resulting sequence revealed 66 orfs including 
BpsA (1282 aa) 
Streptomyces lavendulae 
57% Identity, 69% Similarity 
IndC (1488 aa) 
Erwinia chrysanthemi 
52% Identity, 67% Similarity 




orf34 (nrps2) and orf42 (a putative PPTase). NRPS2 shows homology to two blue-pigment 
producing single-module NRPS enzymes that activate L-Gln: BpsA and IndC (6,7). The nrps2 
locus lacks a MbtH like protein. MbtH-like proteins play an ambiguous role in NRPS systems, 
but they are commonly found within NRPS clusters, and a recent study indicates they play an 
integral role in the NRPS systems with which they are associated by stabilizing A domain 
activity  (104,105). Not all NRPS clusters encode an MbtH homolog. Indeed, the two closest 
homologs of NRPS2, IndC and BpsA, lack an MbtH-like protein within their loci (6,7).  
More extensive bioinformatic analysis determined the domain organization in Figure 4.1, 
which matches that of BpsA and IndC, two indigoidine synthetases (6,7). Additionally, the core 
motifs highlighted in Figures 3.4 through 3.7 of each domain revealed conservative variations to 
some residues, but similar differences were observed in other amino acid sequences in 
characterized NRPS subunits. Significant variances exist between the Ox-2 motifs of BlmIII, 
MtaC, MtaD, and EpoB versus those found in IndC, BpsA, and NRPS2. The altered motifs, 
however, are consistent among IndC, BpsA, and NRPS2, and their presence could be due to a 
subtle difference in function. The analysis of the substrate specificity-conferring residues of 
NRPS2 does not match exactly with a set defined by Stachelhaus, et al., but it did match the 
residues from BpsA and IndC, which activate L-Gln.  When analyzed by the algorithm provided 
by Rausch, et al, L-Gln is also predicted to be the substrate for NRPS2. Therefore, the prediction 
that L-Gln is the amino acid substrate for NRPS2 seems to be reliable (6,7,37,38).   
Based on a predicted common substrate and the strong identity to BpsA and IndC, 
NRPS2 is predicted to produce indigoidine (6,7). Figure 4.2 shows a proposed reaction sequence 
(6,7). This reaction sequence requires the usual NRPS substrate activation and attachment to the 
holo-T domain, but also requires several oxidations by the Ox domain. The first two oxidations 
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proposed here are dehydrogenations to form a double bond between the α- and β-carbons on each 
L-Gln substrate. The next step is the carbon-carbon bond formation between the γ-carbon on 
each L-Gln, and a final dehydrogenation is required to introduce another double bond. While 
oxidation of activated single bonds to double bonds is common for Ox domains, oxidative 
coupling to form a new carbon-carbon bond is not. Thus there is unusual oxidative chemistry in 
these blue pigment synthetases (30,83,85). The oxidizing cofactor is assumed to be FMN, and 
the domain is likely an oxidase, meaning air-reoxidation can regenerate the cofactor (30). 
Confirmation of the cofactor’s identity remains as future work, and further support for this 
reaction sequence could be provided by detailed UV-Vis spectroscopy of the FMN cofactor 
during catalysis, mutagenesis studies of the Ox domain, and crystal structure determination of 
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 Heterologous protein expression studies revealed that the N-terminal hexahistidine fusion 
construct of NRPS2 induced by 0.04 mM IPTG at 15 °C for 24 hours produced the greatest 
amount of soluble protein. An observation in keeping with the functional predictions of NRPS2 
is the intense yellow color of the purified protein, consistent with a FMN cofactor.  Another 
indicator of the function of NRPS2 was the intense blue color in the culture following protein 
expression. Since NRPS2 is similar to indigoidine synthetases and is predicted to require L-Gln, 
it is assumed that this blue pigment is indigoidine. A blue color was observed in the cultures 
expressing NRPS2 fused at the C-terminal to hexahistidine, but to a lesser degree. The blue 
pigment production during NRPS2 expression indicates that not only is the protein functional, 
but also that the E. coli PPTase can prime the T domain with the phosphopantetheinyl prosthetic 
group, an atypical activity when the substrate is an actinomycete NRPS T domain (106,107); this 
assumption will have to be confirmed by mass spectrometry (MS).  The reduced production of 
blue pigment by cultures expressing the C-terminal hexahistidine fusion to NRPS2 could mean 
that the E. coli PPTase has not primed the T domain or that most of the protein produced was 
insoluble. No firm conclusions can be drawn from pigment production by the N-terminal or C-
terminal hexahistidine fusion constructs of NRPS2 without completing the expression and 
solubility study. The bioinformatic analyses and the blue pigment produced by the protein 
strongly suggest that NRPS2 produces indigoidine from two L-Gln units. Without purified 
pigment, nuclear magnetic resonance (NMR) and mass spectrometry (MS) studies cannot be 
completed and the pigment’s identity cannot be confirmed. However, using the purified protein, 
NRPS2 may be partially characterized by in vitro assays. 
 Initial results from the in vitro assays revealed an increase in absorbance at 600 nm that 
appears after five minutes and decreases at later time points. One reason causing this event could 
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be the production of hydrogen peroxide during the reoxidation of the FMN cofactor (30). 
Hydrogen peroxide could not only oxidize the cofactor, but can also oxidize both the product and 
the enzyme. These latter two oxidations would not only continuously degrade the blue pigment 
formed, leading to a loss of absorbance at 603 nm, but could also inactivate the NRPS2 and 
prevent further product formation. After testing to assess the levels of superoxide and hydrogen 
peroxide in the reaction, a solution to this problem may lie in the use of catalase in the in vitro 
assays to degrade the hydrogen peroxide produced during cofactor regeneration and tests 
(30,108). Future work will determine whether or not the inclusion of catalase will be beneficial 
for blue pigment formation by NRPS2.  
 Another question arises concerning blue pigment production in S. laurentii: how is 
production induced? Reverchon, et al, and others indicate that the PecS transcriptional regulator, 
a MarR type regulator, is involved in indigoidine biosynthesis in Erwinia chrysanthemi and 
Streptomyces aureofaciens CCM 3329 (6,109). Studying the transcriptional regulators within the 
nrps2 locus for those similar to PecS could suggest ways in which to activate production in S. 
laurentii.  By adding γ-nonalactone to cultures, Yanagimoto, et al, was able to produce a blue 
pigment in Streptomyces virginiae with identical properties to the blue pigment synthesized by 
NRPS2 (8). The DNA locus for the gene of Streptomyces virginiae’s blue pigment-producing 
enzyme is unavailable. Using the same medium and inducer molecule, however, Takahashi, et al. 
induced blue pigment production in Streptomyces lavendulae (7); S. lavendulae’s BpsA shares 
strong identity with NRPS2. Including γ-nonalactone in S. laurentii cultivated in Y6.5, as 
described by Yanagimoto, et al., resulted in a culture with a green pigment. It is noted that aged 
samples of the semi-purified blue pigment from E. coli also adopt a green hue, perhaps indicative 
of oxidation (data not included). Neither substance was ever analyzed, however, so no direct 
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conclusions can be made. When S. laurentii was cultivated on PGP solid medium, a purple 
substance was excreted into the agar from a confluent plaque (Figure 3.11). S. laurentii produces 
a red pigment on oatmeal agar, and the possibility exists that a red pigment and a blue pigment 
are simultaneously produced when the bacterium is cultivated on PGP medium. To support this 
postulate, the cultures would need to be repeated, and the pigments extracted and purified. 
Additionally, it could be that once an optimum temperature for enzyme activity is identified, this 
information could be applied to induce blue pigment production by S. laurentii.  
 The utility of the blue pigment remains to be determined. It is possible that, like other 
pigments, this pigment could serve as an anti-oxidant (110). Reverchon, et al, also suggests that 
indigoidine scavenges oxygen radicals, a capability contributes to the pathogenicity of E. 
chrysanthemi (6). S. laurentii  produces thiostrepton, but possesses biosynthetic clusters which 
could produce other metabolites (18,21). Although a role for the blue pigment in S. laurentii is 
not currently known, the blue pigment could serve as an anti-oxidant for the bacterium.  
In conclusion, NRPS2 produces a blue pigment thought to be indigoidine. To confirm the 
structure of the blue pigment, a purification protocol must be established to facilitate 
characterization by NMR and MS. To optimize the in vitro blue pigment production, adding 
catalase might be necessary to remove any hydrogen peroxide and prevent degradation of the 
product or the enzyme. A and Ox domain activity assays must be performed, and mutagenesis 
studies can be employed to confirm the function of the T and TE domains. Additionally, once the 
temperature for optimum enzyme activity is determined, blue pigment production in S. laurentii 
must be reattempted at that temperature, even if it means longer incubation periods due to slowed 
growth rates. Additionally, a crystal structure of this unusual Ox domain could facilitate 







Currently, the nrps3 locus has been identified, and, from bioinformatic analyses, a 
backbone structure for the NRPS3 product has been predicted. The assembly of fosmids JA5F6, 
JA9D12, and JA15F8 resulted in a 103052 bp sequence. Analyzing that sequence revealed 74 
orfs including orf30, orf31, orf32, and orf33 which encode the NRPS subunits, NRPS3A, 
NRPS3B, NRPS3C, and NRPS3D. Additionally, orf42 encodes a PPTase, while orf51 encodes 
an MbtH-like protein often associated with NRPS systems (104). It was observed that a NRPS 
subunit, denoted as NRPS4A, lies at the end of the 103052 bp sequence assembled around the 
nrps3 locus. It is unclear whether the MbtH-like protein and other proteins encoded within the 
DNA sequence are part of the NRPS3 biosynthetic gene cluster or that of NRPS4. Delineating 
the product resulting from the NRPS3 biosynthetic gene cluster is complicated by not knowing 


















Figure 4.3 NRPS3 domains and predicted substrates with a proposed backbone for subsequent 
modifications. 
 
Bioinformatic analyses determined the module and domain organization of each NRPS 
homolog in addition to the conserved motifs and substrate specificity of each module. NRPS3A, 
NRPS3C, and NRPS3D encode subunits with A1-MT1-T1, C2-A2-T2-C3-A3-T3-E3, and C4-A4-T4-
TE domain organization respectively. NRPS3B is a discrete MonoOx domain and shows several 
residues conserved with characterized MonoOx domains. Variances exist in the conserved motifs 
of the NRPS3 domains, but those differences are conservative and exist in other characterized 
NRPS subunits. For the MT domain, the M3 motif is missing, but M1 and M2 are present and 
several other residues are highly conserved.  The domain analysis appears to be firm, but the 




















The three subunits, NRPS3A, NRPS3C, and NRPS3D, are predicted to activate L-Phe, L-
Val, Gly, and D-lysergic acid respectively (Table 3.6).  The substrate predictions show some 
variances from what is expected but a few reasons could explain those disparities. The substrate 
for the MonoOx domain is not known. It could hydroxylate a saturated carbon on a free valine, 
and the NRPS3C-M1 A domain could activate the resulting hydrolyated valine. If so, it could 
better explain the variances from the ten residues defined by Stachelahus, et al. in the alignment 
for the NRPS3C-M1 A domain. Additionally, the only known NRPS subunit to activate lysergic 
acid is from a fungal species (103). Specific enzymes are required to produce lysergic acid, but 
those enzymes are not encoded in the nrps3 locus, as expected (103,111). Genes encoding 
lysergic acid biosynthetic enzymes could lie elsewhere in the S. laurentii genome, as do the 
amino acid biosynthetic genes, but this physical separation of biosynthetic genes is rare 
(103,111). Additionally, lysergic acid lacks the free amine required for peptide bond formation 
with the preceding substrate and lysergic acid. After considering these facts, the possibility exists 
that rather than activating lysergic acid, NRPS3D activates a yet-to-be-determined substrate. 
Considering the ambiguity that arises from the bioinformatic analyses, triggering the 
expression of the NRPS3 system and determining the product’s structure might prove easier than 
trying to predict a final product from the biosynthetic gene cluster alone. Future work for NRPS3 
includes analyzing the transcriptional regulators encoded within the nrps3 locus for clues on how 
to trigger the cluster’s expression, structure determination of the cluster’s metabolite, cloning of 









These two genome mining projects of S. laurentii remain incomplete; however the 
direction of the remaining work is known. The NRPS3 system is predicted to produce a novel 
peptide product. Once that product is produced and structurally characterized, the biosynthetic 
cluster can be delineated and fully explored, and biological assays can be used to determine the 
product’s potency against a variety of diseases. On the other hand, since the blue pigment 
produced by NRPS2 is likely indigoidine, the NRPS2 system does not add a new metabolite to 
nature’s arsenal, but further study on indigoidine could reveal medicinally useful characteristics 
of this NRPS product.  Also, NRPS2 is another enzyme that produces a known metabolite. For 
both systems, comparison of the enzymes that can produce a particular compound or structure 
can illuminate critical structures and specific residues that are necessary for the chemistry that 
the enzymes or enzymatic domains perform.  Once these structures and residues are identified, 
biosynthetic engineering may be employed to exploit that chemistry and to produce additional 
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